Suvaporn Anugulruengkitt

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
No aliases are listed.
Publication record
74 papers · 585 citations · H-index 13

PAPERS

Multimodal intervention to decrease central line‐associated bloodstream infection rate in pediatric intensive care unit
20250 citationsauthor #8
Infant Responses to Primary Immunization Following Vaccination in Pregnancy With Varying Doses of Recombinant Acellular Pertussis Vaccine Alone or Combined With Tetanus-Diphtheria
20252 citationsauthor #3
Corrigendum to “Immunogenicity and safety of the live-attenuated tetravalent dengue vaccine (TAK-003) co-administered with recombinant 9-valent human papillomavirus vaccine” [Vaccine 62 (2025) 127558]
20250 citationsauthor #2
Immunogenicity and safety of the live-attenuated tetravalent dengue vaccine (TAK-003) co-administered with recombinant 9-valent human papillomavirus vaccine.
20251 citationsauthor #2
Immunogenicity and safety of the live-attenuated tetravalent dengue vaccine (TAK-003) co-administered with recombinant 9-valent human papillomavirus vaccine.
20250 citationsauthor #2
Attitudes and eligibility of long-acting cabotegravir/rilpivirine treatment among youth living with HIV in a clinical and national cohort in Thailand: a cross-sectional study
20250 citationsauthor #3
Thank you to The Lancet Regional Health – Western Pacific’s clinical and statistical peer reviewers in 2024
20250 citationsauthor #21
Pharmacokinetics of Generic Pediatric Abacavir/Lamivudine Dispersible Tablets in Thai Young Children Living With HIV Weighing Below Twenty Kilograms
20250 citationsauthor #3
Five-Year Trends in Meropenem Utilization and Expenditure in a Pediatric Tertiary Care Hospital in Thailand.
20250 citationsauthor #1
Barriers in implementing antibiotic stewardship programmes at paediatric units in academic hospitals in Thailand: a qualitative study
20252 citationsauthor #1
Pharmacokinetics of Generic Pediatric Dolutegravir Dispersible Tablet in Thai Young Children Living With HIV Weighing Below Twenty Kilograms
20242 citationsauthor #3
Therapeutic Drug Monitoring of High-dose Sulbactam in Pediatric Patients: Preliminary Data From a Prospective Observational Pharmacokinetic Study
20240 citationsauthor #7
Prevalence and Risk Factors of Healthcare-Associated Infections among Hospitalized Pediatric Patients: Point Prevalence Survey in Thailand 2021
20246 citationsauthor #5
Characterization of Clinical and Biologic Manifestations of Chikungunya Among Children in an Urban Area, Thailand: A Retrospective Cohort Study
20243 citationsauthor #3
A reduced-dose recombinant pertussis vaccine booster in Thai adolescents: a phase 2/3, observer-blinded, randomised controlled, non-inferiority trial.
20241 citationsauthor #3
A phase 2 randomized controlled dose-ranging trial of recombinant pertussis booster vaccines containing genetically inactivated pertussis toxin in pregnant women
202310 citationsauthor #6
Immunogenicity of BNT162b2 in children 6 months to under 5 years of age with previous SARS-CoV-2 infection, in the era of Omicron predominance
20232 citationsauthor #9
Outcomes among Thai children with risk conditions hospitalized for pneumococcal disease (invasive or non-bacteraemic pneumonia): A multi-centre, observational study
20233 citationsauthor #12
Good performance of syphilis rapid diagnostic test kits among young key populations in Thailand
20232 citationsauthor #10
Effective and safe transfer of maternal antibodies persisting two months postpartum following maternal immunization with different doses of recombinant pertussis-containing vaccines
20236 citationsauthor #6
Long COVID and Hybrid Immunity among Children and Adolescents Post-Delta Variant Infection in Thailand
202310 citationsauthor #9
Adverse events of antiretroviral prophylaxis regimen for elimination and prevention of mother-to-child transmission among HIV-exposed infants
20230 citationsauthor #1
Point prevalence survey of antibiotic use among hospitalized patients across 41 hospitals in Thailand
202321 citationsauthor #1
Switching efavirenz to rilpivirine in virologically suppressed adolescents with HIV: a multi‐centre 48‐week efficacy and safety study in Thailand
20222 citationsauthor #4
Social Network Strategy to Promote HIV Testing and Linkage to HIV Services among Young men who Have sex with men and Transgender Women in Thailand
20224 citationsauthor #10
Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis: a pharmacokinetic and safety study within the open-label, multicentre, randomised, non-inferiority ODYSSEY trial.
202219 citationsauthor #39
Case Report: Simple Nodular Cutaneous Leishmaniasis Caused by Autochthonous Leishmania (Mundinia) orientalis in an 18-Month-Old Girl: The First Pediatric Case in Thailand and Literature Review.
202216 citationsauthor #1
Characteristics of infection during the first year post pediatric liver transplantation: a 12-year single-center experience
20220 citationsauthor #3
Low Measles Seropositivity Rate among Thai Adolescents in the Thai National Immunization Program
20227 citationsauthor #2
Immunogenicity of BNT162b2 Vaccination against SARS-CoV-2 Omicron Variant and Attitudes toward a COVID-19 Booster Dose among Healthy Thai Adolescents
20227 citationsauthor #10
Immunogenicity to SARS-CoV-2 Omicron variant among school-aged children with 2-dose of inactivated SARS-CoV-2 vaccines followed by BNT162b2 booster
20226 citationsauthor #8
Incidence of healthcare‐associated urinary tract infections in Thai children
20221 citationsauthor #2
Population Pharmacokinetics of Voriconazole in Thai Children Patients with Invasive Aspergillosis
20220 citationsauthor #7
Once-daily dolutegravir-based antiretroviral therapy in infants and children living with HIV from age 4 weeks: results from the below 14 kg cohort in the randomised ODYSSEY trial
202220 citationsauthor #44
Seroprevalence of mumps among children and adolescents in Thailand, 2020.
20227 citationsauthor #1
Keeping It Real: Antibiotic Use Problems and Stewardship Solutions in Low- and Middle-income Countries
202230 citationsauthor #4
Therapeutic drug monitoring of meropenem and pharmacokinetic-pharmacodynamic target assessment in critically ill pediatric patients from a prospective observational study.
202215 citationsauthor #3
Pregnancy and birth outcomes among young women living with perinatally acquired HIV in Thailand and Vietnam
20224 citationsauthor #3
Heterologous Prime-boost of SARS-CoV-2 inactivated vaccine and mRNA BNT162b2 among Healthy Thai Adolescents
20226 citationsauthor #9
Neurological complications associated with influenza in hospitalized children
202223 citationsauthor #4
Keeping It Real: Infection Prevention and Control Problems and Solutions in Low- and Middle-income Countries
202210 citationsauthor #3
Prevention of Emerging Infections in Children
20214 citationsauthor #2
Immunogenicity of 2-dose pre-exposure rabies vaccine co-administered with quadrivalent influenza vaccine in children.
20213 citationsauthor #3
Diagnostic Accuracy of Loop-Mediated Isothermal Amplification (TB-LAMP) for Tuberculosis in Children.
202112 citationsauthor #5
Comparison of Piperacillin Plasma Concentrations in a Prospective Randomized Trial of Extended Infusion versus Intermittent Bolus of Piperacillin/Tazobactam in Paediatric Patients.
202115 citationsauthor #3
High seroprevalence of rubella in Thai children with a 2-dose MMR national immunization policy.
20214 citationsauthor #4
Clinical outcomes of pediatric COVID-19 in a tertiary care center in Bangkok, Thailand
202110 citationsauthor #1
The Pattern of Microorganisms and Drug Susceptibility in Pediatric Oncologic Patients with Febrile Neutropenia
20218 citationsauthor #2
A phase 2 randomized controlled dose-ranging trial of recombinant pertussis booster vaccines containing genetically inactivated pertussis toxin in women of childbearing age
202110 citationsauthor #8
Population pharmacokinetics of meropenem in critically ill infant patients.
20219 citationsauthor #3
Acceptance and outcome of interventions in a meropenem de‐escalation antimicrobial stewardship program in pediatrics
20216 citationsauthor #9
High Prescribing Rates of Third-Generation Cephalosporins in Children Hospitalised with Acute Lower Respiratory Infections at a University Hospital.
20205 citationsauthor #7
SARS-CoV-2 Pandemic Response, Clinical Characteristics and Outcomes at Bangkok's Largest Emerging Diseases Clinical Centre
20200 citationsauthor #5
Pattern and Frequency of Seroreactivity to Routinely Used Serologic Tests in Early Treated Infants with HIV.
20202 citationsauthor #9
Antimicrobial prescription patterns in a tertiary‐care pediatric unit in Thailand
20206 citationsauthor #2
Efficacy of chlorhexidine patches on central line‐associated bloodstream infections in children
20206 citationsauthor #2
Association of Empiric Antibiotic Regimen Discordance With 30-Day Mortality in Neonatal and Pediatric Bloodstream Infection-A Global Retrospective Cohort Study.
202026 citationsauthor #28
Predictive Factors of Severe Adverse Events in Pediatric Oncologic Patients with Febrile Neutropenia
20202 citationsauthor #2
Pediatric and Neonatal Invasive Candidiasis: Species Distribution and Mortality Rate in a Thai Tertiary Care Hospital.
20206 citationsauthor #5
Effects of vitamin D and calcium supplementation on bone mineral density among Thai youth using daily HIV pre‐exposure prophylaxis
20207 citationsauthor #7
Behavioral problems in perinatally HIV-infected young children with early antiretroviral therapy and HIV-exposed uninfected young children: prevalence and associated factors
20207 citationsauthor #4
Gaps in the elimination of congenital syphilis in a tertiary care center in Thailand
20197 citationsauthor #1
A randomized open-label trial of 2-dose or 3-dose pre-exposure rabies prophylaxis among Thai children.
20197 citationsauthor #3
Towards understanding global patterns of antimicrobial use and resistance in neonatal sepsis: insights from the NeoAMR network
201982 citationsauthor #48
Optimizing Vancomycin Use Through 2‐Point AUC‐Based Therapeutic Drug Monitoring in Pediatric Patients
201918 citationsauthor #2
Safety of 6-week Neonatal Triple-combination Antiretroviral Postexposure Prophylaxis in High-risk HIV-exposed Infants.
201912 citationsauthor #1
Nevirapine Concentrations During the First Month of Life and Maternal Efavirenz Washout in High-Risk HIV-Exposed Infants Receiving Triple Antiretroviral Prophylaxis
20194 citationsauthor #1
Impact of a Prospective Audit and Feedback Antimicrobial Stewardship Program in Pediatric Units in Tertiary Care Teaching Hospital in Thailand.
20199 citationsauthor #2
Pharmacokinetics of Rilpivirine and 24-Week Outcomes after Switching from Efavirenz in Virologically Suppressed HIV-1-Infected Adolescents
20184 citationsauthor #2
Intensification of antiretroviral treatment with raltegravir for pregnant women living with HIV at high risk of vertical transmission
201818 citationsauthor #4
Prevalence of Persistent Renal Dysfunction in Perinatally HIV-infected Thai Adolescents
20175 citationsauthor #5
Prevalence and Characteristics of Pediatric Healthcare Workers without Immunity to Varicella zoster Virus.
20173 citationsauthor #1
Clinical Features and Survival Outcomes of Invasive Aspergillosis in Pediatric Patients at a Medical School in Thailand.
20167 citationsauthor #1
Immunogenicity of a Japanese encephalitis chimeric virus vaccine as a booster dose after primary vaccination with SA14-14-2 vaccine in Thai children.
201614 citationsauthor #3

TIMELINE

2016 21 citations

2017 8 citations

2018 22 citations

2019 139 citations

2020 67 citations

2021 81 citations

2022 177 citations

2023 54 citations

2024 12 citations

2025 5 citations

COAUTHOR MAP

CONCEPT FOOTPRINT